Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dental Pulp MSCs for Knee Osteoarthritis
NCT04130100Phase 1Unknown
- Sponsor
- CARsgen Therapeutics
- Start
- Apr 2019
- Primary completion
- Sep 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised trial of dental pulp mesenchymal stem cells in knee osteoarthritis (OA) (3 arms), sponsored by CARsgen Therapeutics. Primary endpoints: Kellgren and Lawrence's rating at 12 month and WOMAC score at 12 month. Status: unknown.
02
Drugs
dental pulp mesenchymal stem cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04130100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04130100.